Drug developed in Cambridge approved for treatment of multiple sclerosis
A transformational new treatment for multiple sclerosis (MS) - the result of over three decades of research in Cambridge - was approved today by the EU agency responsible for regulating new drugs. The approval concludes a nearly 40-year epic journey from fundamental research to discovery of an effective treatment for active relapsing MS.
Record year for University investment in spin-outs
The University of Cambridge invested nearly £2.3 million last year to support the development of Cambridge spin-outs.
How does your garden grow?
A simple mixture of organic waste, such as chicken manure, and zeolite, a porous volcanic rock, has been developed into a powerful fertiliser which can also reclaim desert or contaminated land.
Cambridge Epigenetix launches its first product
A DNA analysis tool developed by a University spin-out could represent a ground-breaking development for the epigenetics industry, leading to important advances in drug discovery, diagnostics and our fundamental understanding of biology.
Technology lets buildings breathe
Natural ventilation technology which has the potential to reduce heating bills by as much as 50%, while drastically reducing energy consumption, has been developed by a Cambridge spin-out.
Carbon ‘candy floss’ could help prevent energy blackouts
Ultra-light, high performance electrical wiring, made from carbon instead of copper, has been developed in a usable form for the first time.
New treatments for pain and MS being developed in open innovation programme
Two revolutionary treatments which could alleviate pain in people with hypersensitivity to heat, and provide a new regenerative therapy with MS sufferers, are being developed by University of Cambridge researchers at Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus.
Towards the ‘holy grail’ of anticoagulant drugs
New Cambridge spin-out raises $11 million in funding to develop revolutionary new drug for thrombosis, which causes heart attacks and strokes.
Sphere Fluidics wins award for academic spin-outs
University of Cambridge spin-out Sphere Fluidics was among the winners at the ACES awards – the only pan-European awards for academic spin-outs – held earlier this week in Brussels.
Flexible opals have huge potential
A synthetic material which mimics the brightest and most vivid colours in nature, and changes colour when twisted or stretched, has been developed by researchers at the University of Cambridge, and could have important applications in the security, textile and sensing industries.
New device could make diagnosing disease as simple as breathing
A range of diseases and conditions, from asthma to liver disease, could be diagnosed and monitored quickly and painlessly just by breathing, using gas sensing technology developed by a Cambridge spin-out.
Cambridge spin-out helps to fight online banking fraud
A security solution which protects against the most serious threat to online banking customers, responsible for millions in annual losses, is being rolled out across Europe by a Cambridge spin-out.
Cambridge spin-outs among 'Business Weekly' award winners
Two University of Cambridge spin-outs were among the winners at the annual Business Weekly awards, held earlier this week at Queens’ College, Cambridge.
Generous tax incentives for investors in Cambridge University spin-outs
After the success of last year’s University of Cambridge Enterprise Fund, the University is launching a second fund for the 2013-14 tax year, in order to support new companies based on Cambridge research.
Competition winners build a better battery
A new battery technology provides double the energy storage at lower cost than the batteries that are used in handheld electronics, electric vehicles, aerospace and defence.
Horizon Discovery wins Most Promising Company at World Conference on Personalised Medicine
Award based on technology, performance to date, and forward plans
Cambridge Enterprise announces 2012 results
More than £1 billion in funding has been raised by companies with roots in Cambridge research, according to year-end results from Cambridge Enterprise, the University’s commercialisation arm.
Centre helps to develop smarter infrastructure
A team from the University of Cambridge Centre for Smart Infrastructure and Construction have developed a mechanical amplifier to convert ambient vibrations into electricity more effectively, which could be used to power wireless sensors for monitoring the structural health of roads, bridges and tunnels.
Cambridge student entrepreneurs win national business plan competition
A team of aspiring biotechnology entrepreneurs from the University of Cambridge has won the Biotechnology Young Entrepreneurs Scheme (YES) 2012.
Funding the next big low carbon idea
Shell UK has launched a search to find the next big low carbon business innovation.
Cambridge SEIS Fund makes its first investments
The University of Cambridge Enterprise Fund has made its first investments in three companies: Cambridge CMOS Sensors, Inotec AMD and DefiniGEN.
£60 million boost for science innovation
Cambridge has received new funding as part of a £60m investment in UK universities to help encourage the development of new industrial collaborations, products and companies based on University research.
Cambridge software improves quality of sound for hearing aid users
A new software product developed by researchers at the University of Cambridge could greatly improve sound perception for users of hearing aids.
Sensors for the real world
Over the past decade there has been an increased interest in developing resonators for gravitmetric sensing; however, the sensors’ response to variations in temperature has prevented them from being used outside the laboratory. New sensors developed by researchers at the University of Cambridge negate the effects of temperature so that they may be used in industries including health care,…
Cambridge inventor wins innovation competition
A University of Cambridge inventor has won first prize in the 2012 Innovation Competition organised by Health Enterprise East, the NHS Innovation Hub for the Eastern Region.